We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Group: FDA Needs Penalties for Postmarket Study Delays
Group: FDA Needs Penalties for Postmarket Study Delays
March 10, 2006
A public advocacy group is calling on the FDA to impose financial penalties on companies that submit their annual postmarket study reports late, arguing that fines are necessary to ensure that results are issued on time.